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E2F transcription factors and their regulatory partners, the pocket proteins (PPs), have
emerged as essential regulators of stem cell fate control in a number of lineages. In
mammals, this role extends from both pluripotent stem cells to those encompassing
all embryonic germ layers, as well as extra-embryonic lineages. E2F/PP-mediated
regulation of stem cell decisions is highly evolutionarily conserved, and is likely a
pivotal biological mechanism underlying stem cell homeostasis. This has immense
implications for organismal development, tissue maintenance, and regeneration. In this
article, we discuss the roles of E2F factors and PPs in stem cell populations, focusing
on mammalian systems. We discuss emerging findings that position the E2F and
PP families as widespread and dynamic epigenetic regulators of cell fate decisions.
Additionally, we focus on the ever expanding landscape of E2F/PP target genes, and
explore the possibility that E2Fs are not simply regulators of general ‘multi-purpose’ cell
fate genes but can execute tissue- and cell type-specific gene regulatory programs.
Keywords: stem cell fate, neural precursor cell (NPC), pocket proteins, transcription, epigenetics, stem cells, cell
cycle, E2F transcription factors
Introduction
Since the discovery of the retinoblastoma protein (pRb) as a potent tumor suppressor two and a
half decades ago, the pocket protein (PP) family (including pRb, p107 and p130) and their best
characterized interacting partners, the E2F transcription factor family, have been under intensive
scientiﬁc investigation. It is now clear that the PP and E2F proteins are not only important reg-
ulators of cellular proliferation but of multiple cellular processes, many of which impact cell fate
decisions. While cell cycle-independent roles for E2Fs and PPs have been known for some time
(Lee et al., 1994), what remains to be fully clariﬁed, however, are the mechanisms by which the PP
and E2F families control such diverse functions.
The advent of genomics and other systems biology approaches to study the role and mode of
action of transcription factors has contributed greatly to our mechanistic understanding of E2F/PP
function. Additionally, work by many groups, predominantly over the past decade, focused on
linking causative target genes to non-canonical E2F/PP biological functions has greatly enriched
our view of E2Fs and PPs as regulators of not only cell cycle control, but also key cell fate deci-
sions. Collectively, these studies suggest that E2fs and PPs are dynamic transcriptional regulators
that can control diverse cellular functions by regulating genes directly involved in those processes,
potentially in a highly tissue-speciﬁc manner.
In this review we discuss the current understanding of how the classical cell cycle regulatory
pathway impacts cell fate decisions at the level of E2F/PP-dependent transcriptional regulation.
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Speciﬁcally, we highlight ﬁndings that position E2F and PP
factors as fundamental regulators of cell fate control in stem
and progenitor populations. Furthermore, we discuss emerging
mechanisms by which E2Fs and PPs may execute cell type-
speciﬁc gene regulatory programs in order to regulate cell fate
control in a specialized manner.
Cell Cycle Regulation by E2Fs and PPs
The eukaryotic cell cycle is controlled in large part by the cycli-
cal expression of important eﬀector molecules. For example,
the expression of enzymes that participate in DNA replication
or chromosome segregation typically occurs when these pro-
teins are needed, in S or M phase, respectively. While a great
deal of regulation of this process occurs at the level of con-
trolled synthesis-degradation of certain regulatory proteins (most
notably the cyclins), transcriptional control by sequence-speciﬁc
E2F transcription factors and their regulation by PPs is also heav-
ily implicated as a central mechanism driving cell cycle regulation
[reviewed in Dick and Rubin (2013)].
To date, eight E2F genes, giving rise to 10 distinct E2F pro-
teins, have been identiﬁed in mammals [reviewed in Chen et al.
(2009b)]. While E2F factors exhibit varying degrees of sequence
and structural diﬀerences, the DNA binding domain is strikingly
well-conserved among family members. This beﬁts ﬁndings that
E2F family members typically exhibit signiﬁcant overlap in their
target genes in a given tissue (Xu et al., 2007). The classical view of
E2F/PP activity in cell cycle control (Cam and Dynlacht, 2003) is
that unphosphorylated PPs form transcriptional repressive com-
plexes with repressor E2Fs (E2F3b, E2F4, and E2F5) in quiescent
and early G1 phase cells, to silence the expression of cell cycle
regulatory and eﬀector genes. In the presence of mitogenic stim-
uli, cyclin D-CDK4/6 initiates the phosphorylation of PPs, which
leads to the disruption of the E2F/PP repressive complexes and
nuclear export of the E2F factors. Concomitantly, activator E2F
proteins (E2F1, E2F2, and E2F3) become expressed and stimu-
late the transcription of cell cycle genes that allow cells to pass the
G1/S transition.
An Expanded Role for E2Fs and PPs in
Controlling Stem and Progenitor Cell Fate
Decisions
As a central regulator of proliferation and cell cycle exit, the
E2F/PP pathway is functional in essentially all cell types, and
during all stages of development. Investigations into the biologi-
cal roles of cell cycle regulatory proteins beyond ﬁbroblasts and
tumor-derived cell lines, speciﬁcally within tissue-speciﬁc pri-
mary stem and progenitor cell populations, have revealed that
this pathway controls a number of cellular processes, many of
which impact key stem cell fate decisions. This is exempliﬁed col-
lectively by ﬁndings that loss of pRb and/or the other PPs results
in stem cell expansion in many tissues, often accompanied by
decreased cell survival, inhibition of diﬀerentiation, or altered lin-
eage choices upon diﬀerentiation [reviewed in Sage (2012), Cai
et al. (2013), De Sousa et al. (2014)]. Deregulation of E2F activity
is strongly implicated in driving many of these phenotypes, and
the existing literature now suggests a fundamental widespread
role for these transcriptional regulators in cell fate determination.
Similar to the strong evolutionary conservation of a role in
cell cycle regulation (Dimova et al., 2003; Stevaux et al., 2005;
Kirienko and Fay, 2007; Hirano et al., 2008; Acharya et al., 2012;
Korenjak et al., 2012; Kudron et al., 2013), E2F/PP-mediated
control of stem cell fate decisions also appears to be deeply
conserved. The PP and repressive E2F orthologs in the highly
regenerative freshwater planarian (Smed-Rb and Smed-E2F4-1,
respectively) are required for the self-renewal, maintenance and
survival of pluripotent adult stem cells in this system (Zhu and
Pearson, 2013). Additionally, a clear role for E2Fs and PPs in
regulating stem cell fate decisions was in fact ﬁrst demonstrated
in the plant species Arabidopsis thaliana. In this system, func-
tional suppression of the single PP RBR or over-expression of the
transcriptional activator E2Fa leads to a speciﬁc increase in the
number of stem cells in the root meristem; conversely, RBR over-
expression causes these cells to rapidly diﬀerentiate (Wildwater
et al., 2005). RBR loss also results in an expanded stem cell pool
and aberrant fate determination in the male germline (Chen et al.,
2009c).
A Multi-Tissue Cell Fate Regulatory
Role for E2F and Pocket Proteins
The earliest indications that the functional importance of the
cycle machinery extends beyond the regulation of cell cycle
progression in mammalian systems came from analysis of Rb1
knockout mice. Rb1-deﬁcient embryos die between embryonic
day 13.5–15.5 and they are marked by ectopic mitoses and exten-
sive apoptosis throughout the developing nervous system (Clarke
et al., 1992; Jacks et al., 1992; Lee et al., 1992; Morgenbesser et al.,
1994). This demonstrated a potential novel role for pRb in cell
survival. These and subsequent studies additionally revealed an
essential role for pRb in cell cycle exit and cellular diﬀerentia-
tion, predominantly within the myoblast, neural, erythroid, and
trophoblast stem cell lineages (Clarke et al., 1992; Jacks et al.,
1992; Lee et al., 1992, 1994; Slack et al., 1998; de Bruin et al.,
2003; MacPherson et al., 2003; Wu et al., 2003). The aberrant
trophoblast stem cell diﬀerentiation induced by pRb loss was
later attributed to deregulated E2f3 activity (Wenzel et al., 2007)
and antagonism between the E2f3 and E2f7&8 factors (Ouseph
et al., 2012). Further, conditional loss of pRb in muscle precur-
sors (Rb-ﬂox:Myf5-Cre) led to a reduced diﬀerentiation capacity
and increased rates of apoptosis (Huh et al., 2004), demon-
strating the cell autonomous nature of these eﬀects. Together,
these phenotypic studies suggested an essential role for pRb
in embryonic development and post-natal survival, character-
ized by widespread roles in cellular proliferation, survival, and
diﬀerentiation.
Deﬁciency in PPs other than pRb revealed additional roles for
this family in diﬀerentiation and survival. Compound deﬁciency
for both pRb and either p107 or p130 results in phenotypes sim-
ilar to Rb1 knockouts, but these mice die earlier and display an
exacerbation of proliferative and apoptotic phenotypes in a num-
ber of tissues, including the central nervous system (CNS; Lee
et al., 1996; Lipinski and Jacks, 1999; Sage et al., 2000; Berman
et al., 2009). Mice lacking both p107 and p130 also exhibit
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perinatal lethality and have defects in chondrocyte and epidermal
diﬀerentiation (Cobrinik et al., 1996; Ruiz et al., 2004). Finally,
loss of all three PPs demonstrated an essential role in early devel-
opment and pluripotency, as these mice die by E9.5-11.5 with
evidence of widespread elevated proliferation and cell death (Wirt
et al., 2010). Furthermore, triple PP-deﬁcient human embryonic
stem cells (ESCs) exhibit cell cycle arrest and death, by activa-
tion of p53 and p21 signaling (Conklin et al., 2012). Thus, loss of
PPs leads to marked defects in development and diﬀerentiation
of many cell and tissue types.
In the tumor prone retina, pRb is required in a cell
autonomous manner for progenitor cell exit and diﬀerentiation
of rod photoreceptor cells (Zhang et al., 2004), while the PP fam-
ily is together required to maintain horizontal interneurons in
a post-mitotic state (Ajioka et al., 2007). In the absence of PPs,
horizontal cells maintain their diﬀerentiated state but begin to
clonally expand, giving rise to metastatic retinoblastomas. pRB
loss in human retinal cone cells has also been demonstrated to
drive cell cycle exit and to promote retinoblastoma-like tumor
development (Xu et al., 2014). E2fs themselves are also heavily
involved in the proliferation, survival, and diﬀerentiation of dis-
tinct neuronal cell types in the retina (Chen et al., 2007, 2013).
Additionally, E2F1 and hyper-phosphorylated pRB play impor-
tant roles in post-mitotic neurons in the adult brain, speciﬁcally
in eﬀecting the calpain-induced neuronal cell death observed
in a number of CNS neurocognitive disorders, including HIV-
induced encephalitis, Alzheimer disease, Parkinson’s disease, and
amyotrophic lateral sclerosis (Giovanni et al., 2000; Jordan-
Sciutto et al., 2001; Ranganathan and Bowser, 2003; Höglinger
et al., 2007; Akay et al., 2011; Zyskind et al., 2015). Thus, deter-
mination and maintenance of cell fate by E2F and PPs is a key
feature underlying both tissue homeostasis and disease pheno-
types.
Mice deﬁcient in only p107 or p130 suﬀer much less severe
phenotypes than pRb knockouts, and are viable and fertile
(Cobrinik et al., 1996; Lee et al., 1996). However, a deeper analy-
sis of these models, particularly for p107, revealed key functions
for the E2F/PP pathway in not only diﬀerentiation, but also direct
regulation of stem and progenitor cell maintenance. For example,
p107 is required in the developing and adult forebrain to both
promote neuronal diﬀerentiation and limit neural precursor cell
(NPC) expansion (Vanderluit et al., 2004, 2007), and for proper
lineage commitment in adipose stem cells (Scimè et al., 2010; De
Sousa et al., 2014).
Many PP-mediated phenotypes that impact fundamental stem
and progenitor cell fate decisions have been shown to be fully
or at least partially E2F-dependent, typically due to a clear
transcriptional-based mechanism (Chen et al., 2007, 2009a, 2013;
McClellan et al., 2007, 2009; Wenzel et al., 2007; Chong et al.,
2009a; Shamma et al., 2009; Hu et al., 2012; Rotgers et al., 2014).
Additionally, E2F-deﬁciency alone, even loss of single E2F family
members, disrupts cell fate regulation in a number of cell types
(McClellan and Slack, 2007; Ruzhynsky et al., 2007; Asp et al.,
2009; Chen et al., 2009a, 2013; Chong et al., 2009b; Julian et al.,
2013; Suzuki et al., 2014). Thus, it is clear that transcriptional
regulation mediated by E2Fs and PPs is an important functional
mechanism underlying stem cell fate determination (Figure 1).
Intersection of Cell Cycle Regulation
with Cell Fate Control
Cell cycle dynamics are in fact tightly connected with stem cell
fate. Cellular diﬀerentiation occurs when a primitive, progeni-
tor cell type acquires more specialized functions, and many cell
diﬀerentiation events are accompanied by changes in prolifera-
tion status. For instance, skeletal muscle precursors irreversibly
exit the cell cycle once they terminally diﬀerentiate into myocytes
(Bischoﬀ and Holtzer, 1969; Nadal-Ginard, 1978; Olson, 1992),
and slow-dividing stem cells of the intestinal crypt give rise
to transit-amplifying precursors that proliferate quickly before
undergoing terminal diﬀerentiation into one of the intestinal
cell types [reviewed in Potten and Loeﬄer (1990)]. The self-
renewal or diﬀerentiation potential of pluripotent stem cells is
tightly linked to cell cycle phase, where G1 phase cells are poised
for diﬀerentiation (Sela et al., 2012; Chetty et al., 2013; Singh
et al., 2013). Similarly, NPCs lengthen their G1 phase and shorten
S phase upon commitment to diﬀerentiation (Takahashi et al.,
1995; Calegari et al., 2005; Arai et al., 2011), and disrupted cell
cycle dynamics severely aﬀect the balance between NPC popula-
tions and newly born neurons in the brain (Lange et al., 2009;
Lim and Kaldis, 2012). Gain- or loss-of-function studies have
revealed key roles for cell cycle proteins in controlling cellular
processes and cell fate decisions that inﬂuence cortical develop-
ment, neurogenic output and the number and behavior of neural
stem and progenitor cells (these studies will be discussed fur-
ther below). As cell cycle regulation and cell fate decisions are so
closely interconnected, one might therefore argue that the non-
canonical activities of E2Fs/PPs that have now been identiﬁed
in stem and progenitor cells are a secondary consequence of cell
cycle control.
One potential mechanism by which E2F- and PP-dependent
regulation of cell cycle genes may indirectly inﬂuence cell fate
decisions is through alteration of cell cycle kinetics. The “cell
cycle length hypothesis” postulates that the time spent by tis-
sue progenitors in the G1 phase might increase the ability of
these cells to respond to diﬀerentiation cues, for example the
response to certain morphogens (Lange and Calegari, 2010). In
this scenario, PPs would control cell fate in cooperation with E2F
factors by silencing their canonical cell cycle target genes, block-
ing S-phase entry and lengthening the G1 phase. This mechanism
has been proposed for adipose and neural precursors (Calegari
and Huttner, 2003; De Sousa et al., 2014). However, a number
of recent studies have highlighted direct, cell cycle-independent
roles for E2Fs in controlling many of these diverse processes.
Phenotypic studies in a number of tissues have oﬀered clear evi-
dence that E2Fs and PPs can regulate cell fate decisions that
impact stem cell maintenance and diﬀerentiation without simul-
taneously aﬀecting cell cycle dynamics (Ceol and Horvitz, 2001;
McClellan et al., 2007; Vanderluit et al., 2007; Chen et al., 2009a;
Chong et al., 2009b; Wenzel et al., 2011; Julian et al., 2013;
Kareta et al., 2015). A primary, fundamental role for E2Fs out-
side of cell cycle regulation is further supported by ﬁndings in
the nematode Caenorhabditis elegans, where the E2F, DP and
pRb orthologs elf-1, dpl-1 and lin-35, are essential for fertility
by controlling diﬀerentiation of precursor cells during vulval
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FIGURE 1 | E2Fs/PPs control diverse classes of cell fate regulatory
processes and associated genes. Transcriptional regulation of
non-classical, cell cycle-independent, genes by E2Fs and PPs has been
associated with a number of biological processes that impact stem cell
fate. These processes include: quiescence, proliferation, metabolism,
differentiation and lineage choice, cell death and survival, migration of
newly committed cells, stem cell self-renewal, and cellular
reprogramming (specifically, reprogramming of fibroblasts to pluripotent
SCs). Where examples are known, select cell fate-associated genes
that have been confirmed as functional targets of E2Fs/PPs are
indicated in red italicized font. References for cell death/survival genes
are as follows: (Irwin et al., 2000; Moroni et al., 2001; Hershko and
Ginsberg, 2004; Tracy et al., 2007). See the main text or Table 1 for
additional references.
development by antagonizing Ras-MAPK signaling, as opposed
to regulating proliferation (Ceol and Horvitz, 2001; Myers and
Greenwald, 2005).
A pivotal question remains, however, in determining whether
E2Fs and PPs can truly regulate cell fate processes in a direct, cell
cycle-independent manner. As the basic functional role of E2Fs
is to transcriptionally regulate gene expression, it is important to
establish whether they can directly regulate expression of genes
that control cell fate processes.
Unbiased Identification of E2f Target
Genes Suggest a Widespread
Transcriptional Role in Cell Fate
Determination
Despite the extensive and ever increasing evidence of a fun-
damental biological role for E2F and PPs in stem cell fate
control, the underlying cellular mechanisms are only beginning
to be clariﬁed. As concerted E2F/PP activity ultimately aﬀects
transcriptional regulation of E2F target genes, it is highly likely
that the genes that are bound and regulated by E2Fs are piv-
otal elements of how this pathway controls cell fate decisions.
A range of potential scenarios exist, however, whereby E2Fs may
have the capacity to regulate genes directly involved in cell fate
regulation, or these eﬀects may instead be indirect, caused by sec-
ondary eﬀects of cell cycle gene expression and changes in cell
cycle dynamics. Understanding these mechanisms at the gene
regulatory level is therefore paramount to determining the true
nature and extent of E2F/PP function in stem cell biology.
Early Identification of E2F and PP Target
Genes
Among the ﬁrst genomic studies to take a global look at E2F tar-
gets were those employing DNA microarrays to perform gene
expression proﬁling after gain- or loss-of-function of E2F and
PP family members. One serious limitation of this approach
stems from its inability to distinguish direct and indirect gene
regulatory relationships (Ishida et al., 2001; Kalma et al., 2001;
Markey et al., 2002; Polager et al., 2002; Stanelle et al., 2002;
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Vernell et al., 2003; Blais and Dynlacht, 2007). For this reason,
experiments of chromatin immunoprecipitation (ChIP) coupled
to promoter DNA microarray hybridization were undertaken.
The earliest studies used microarrays with long, PCR-generated
probes limited to a subset of known genes, typically focused
on promoter regions of cell cycle-related genes. These investi-
gations were instrumental in reaﬃrming previous ﬁndings that
PPs and E2Fs directly regulate a large cohort of genes associ-
ated with proliferative control (Cam and Dynlacht, 2003; Blais
and Dynlacht, 2004, 2007; Bracken et al., 2004; Dimova and
Dyson, 2005). These canonical target genes include those encod-
ing: key cell cycle regulators (e.g., Cyclin proteins, E2Fs them-
selves), nucleotide synthesis and DNA replication enzymes (e.g.,
TK, DHFR, DNA polymerase alpha), DNA repair proteins (e.g.,
RAD51, the Fanconi anemia proteins), and proteins involved
in chromosome organization and segregation (e.g., histones,
HMG1, SMC proteins).
This canonical view of E2F-dependent regulation of cell cycle
associated genes has come from studies carried out not only in
human or rodent cells, but also in ﬂies, nematodes, and plants
(Dimova et al., 2003; Stevaux et al., 2005; Kirienko and Fay,
2007; Hirano et al., 2008; Acharya et al., 2012; Korenjak et al.,
2012; Kudron et al., 2013). Thus, the role of the E2F/PP signaling
node as a key cell cycle regulator, as well as the basic mecha-
nisms of gene regulation by E2Fs and PPs, has deep evolutionary
roots.
E2Fs and PPs as Widespread Regulators of
Genes Associated with Stem Cell Fate
Two key advances have contributed to changing the way we now
look at the degree of functional diversity of the E2F/PP path-
way. First, rapid technological advances in systems biology have
increasingly allowed us to perform larger, genome-wide scale
screens that are less biased and more likely to provide a com-
prehensive view of transcription factor targets than the earliest
studies of E2F/PP target genes. Second, screens have been per-
formed in a larger diversity of cell types, and in various cell
diﬀerentiation paradigms, going beyond ﬁbroblasts and cancer
cell lines. The data gathered from these studies have revealed that
E2Fs and E2F/PP complexes target the promoters of numerous
genes with a much broader range of functional associations than
was originally perceived, not only the canonical set of cell cycle
genes, many of which directly instruct key cell fate decisions.
The unbiased identiﬁcation of E2F/PP target genes, together with
the analysis of genetic knock-out animal models, has revealed
an incredible diversity of function for the E2f and PP families
that cannot be fully appreciated solely with the classical cell cycle
regulatory model.
Inmammalian cells, large-scale ChIP-chip and ChIP-Seq anal-
yses of E2F target genes that have been performed to date are
predominantly focused on identifying E2F1 and E2F4 binding
sites, and have been reported in a relatively limited panel of cul-
tured and immortalized cell types (Conboy et al., 2007; Xu et al.,
2007; Lee et al., 2011). Unbiased identiﬁcation of genes bound
by E2F3 (including both the E2F3a and E2F3b isoforms) have to
our knowledge been reported to date only in C2C12 myoblasts
and myotubes (Asp et al., 2009), in mouse embryonic ﬁbroblasts
(von Eyss et al., 2012) and in primary murine NPCs (Julian et al.,
2015). E2F3a&b, however, exhibit pivotal roles in a number of tis-
sue systems and cellular processes, including gross mammalian
embryonic development (Tsai et al., 2008), neurogenesis (Chen
et al., 2007; McClellan et al., 2007, 2009; Julian et al., 2013), myo-
genesis (Asp et al., 2009), Sertoli cell maturation and survival
(Rotgers et al., 2014), and maintenance of trophoblast stem cells
(Wenzel et al., 2007). Given its broad functional roles, unbiased
identiﬁcation of E2F3 target genes in a greater diversity of cell
types will therefore be greatly informative of the conserved and
possible tissue-speciﬁc mechanisms by which E2F/PPs regulate
cell fate decisions.
Despite the relatively limited data currently available, genome-
wide DNA binding studies have been instrumental in establishing
novel cellular functions for the E2F/PP pathway. Furthermore,
they have signiﬁcantly expanded both the cell cycle-independent
roles in which this pathway is implicated, as well as the extent
to which it is thought to be integrated transcriptionally in each
of these functions. These studies have revealed that E2Fs bind to
the regulatory regions of not 100s, as was our previous under-
standing, but 1000s of genes, in a relatively consistent manner
across cell types. Whereas this pathway has been broadly impli-
cated in the regulation of genes involved in not only cell cycle
control, but also apoptosis, development, and diﬀerentiation for
some time (Müller et al., 2001), genome-wide analyses are now
demonstrating that E2F factors are in fact poised to control a
large network of often 100s of genes involved in each of these bio-
logical functions. Additionally, recent studies that have expanded
analyses to identify genes bound or regulated at the expression
level by E2F/PPs outside of cancerous and immortalized cell lines,
speciﬁcally in pluripotent, epidermal, muscle and neural stem
cells (Asp et al., 2009; Lorz et al., 2010; Yeo et al., 2011; von
Eyss et al., 2012; Kareta et al., 2015) have revealed large groups
of target genes involved in many specialized functions that inﬂu-
ence cell fate. These functions broadly include the regulation
of cellular metabolism, quiescence, stem cell self-renewal, and
tissue-speciﬁc diﬀerentiation programs. These ﬁndings, and the
large number of potential target genes uncovered for each pro-
cess, suggest a widespread transcriptional role for E2Fs and PPs
in stem cell fate regulation.
Functional Evidence that E2Fs and PPs
Control Transcription of Cell
Fate-Associated Genes
Functional assays and analyses of genetic mouse models have
provided important biological conﬁrmation that E2Fs and PPs
can indeed aﬀect cell fate outcomes in stem and progenitor cells
by transcriptionally regulating genes that directly control cell fate
processes. E2F and PP family members have been implicated as
important biological regulators of a number of processes that
impact stem and progenitor cell fate, including: death and sur-
vival, quiescence, self-renewal, proliferation, diﬀerentiation, and
migration (Figure 1). While classical cell cycle control is impli-
cated in some processes, such as quiescence (Sage et al., 2003;
Lorz et al., 2010; Andrusiak et al., 2013), many genes that have
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direct, seemingly cell cycle-independent roles in cell fate reg-
ulation have been validated as true functional E2F/PP targets
(Figure 1 and Table 1). Although the number of such validated
genes is currently limited, considering the large number of poten-
tial target genes uncovered by genome-wide analyses, the ﬁndings
that have been made provide important proof of concept that this
cell fate regulatory mechanism is important across multiple cell
lineages.
Regulation of Genes that Promote or Inhibit
Differentiation
A number of genes that directly control progenitor cell com-
mitment to diﬀerentiation or lineage choice have been validated
as biologically relevant E2F/PP target genes. For instance, E2f1
stimulates expression of the Peroxisome proliferator-activated
receptor PPARγ in adipogenic progenitors to promote their
expansion, while E2f4 conversely represses PPARγ expression
to limit expansion and promote adipocyte diﬀerentiation (Fajas
et al., 2002b). Functional analysis of myogenesis, along with
direct identiﬁcation of the genes both bound and regulated
at the mRNA level by E2fs in proliferating and diﬀerentiating
myoblasts revealed that E2f3b is required to repress expression
of key myogenic factors, such as MyoD, during diﬀerentia-
tion (Asp et al., 2009). Furthermore, E2f1 stimulates pancreatic
diﬀerentiation by activating expression of the Ngn3 promoter
in embryonic endocrine precursors (Kim and Rane, 2011). In
the CNS, regulation of the neurogenesis and migration related
genes Dlx1/Dlx2 and Neo1 (Neogenin) are linked to pRb and
E2f-mediated control of interneuron speciﬁcation and neuronal
migration during development (Andrusiak et al., 2011; Ghanem
et al., 2012). E2F/PP-mediated transcriptional regulation of fac-
tors that potentiate diﬀerentiation has also been linked to tumori-
genesis, where E2f1-mediated transcription of PPARγ and Fatty
acid synthase (Fasn) drives proliferation and survival of medul-
loblastoma tumors (Bhatia et al., 2012; Bhasin et al., 2013), and
activation of multiple Notch pathway genes by E2fs serves to
limit tumor expansion in hepatocellular carcinoma (Viatour et al.,
2011).
Regulation of Stem Cell Maintenance Genes
by E2Fs and PPs
Recent studies have substantiated a direct transcriptional role for
E2Fs and PPs in not only the regulation of diﬀerentiated cell
fates, but also in the control of stem cell self-renewal and pro-
liferation. Studies of E2F/PP biological function and associated
target genes in the CNS in particular have signiﬁcantly increased
our understanding of how E2F/PP activity can impact stem cell
function. In the adult CNS, loss of E2f1 leads to a reduction
of neural stem and progenitor cell divisions in the proliferative
zones, resulting in reduced hippocampal neurogenesis (Cooper-
Kuhn et al., 2002). In the retina, pRb and E2f3a together con-
trol diﬀerentiation, speciﬁcally of starburst amacrine cells (Chen
et al., 2007). In the developing telencephalon, however, p107
and E2f3a/b regulate the balance between NPC maintenance,
self-renewal and diﬀerentiation, and these activities are strongly
associated with transcriptional regulation of the core stem cell
self-renewal/maintenance genes Sox2 and the Notch/Hes path-
way (Vanderluit et al., 2004, 2007; Julian et al., 2013). E2f4 also
promotes neural stem cell self-renewal, and this has been linked
to regulation of the Sonic Hedgehog (Shh) pathway (Ruzhynsky
TABLE 1 | Listed here are the stem and progenitor cell populations for which E2Fs and PPs have demonstrated cell fate regulatory roles.
Stem cell population E2F and PP factors
implicated
Cell fate process
affected
Target gene(s) Reference (for target genes)
Pluripotent SC pRb, p107, p130, E2f2,
E2f4
Self-renewal,
Reprogramming to
pluripotency, Survival
Sox2∗∗ Yeo et al. (2011), Li et al. (2012), Kareta
et al. (2015)
Neural and retinal
precursors
pRb, p107, E2f1, E2f2,
E2f3, E2f4
Self-renewal, Proliferation,
Differentiation Migration,
Survival
Sox2, Pax6, Notch and Shh
pathways, Fgf2, Dlx1, Dlx2,
Neo1, Nrp1∗∗
Vanderluit et al. (2004, 2007), Jiang et al.
(2007), McClellan et al. (2007, 2009),
Ruzhynsky et al. (2007), Andrusiak et al.
(2011), Ghanem et al. (2012), Julian et al.
(2013, 2015)
Myoblast pRb, p107, E2f1, E2f3,
E2f4
Proliferation, Differentiation,
Survival
MyoD∗∗ Asp et al. (2009)
Hematopoietic SC pRb, p107, p130, E2f8 Quiescence, Expansion,
Differentiation
Adipogenic progenitor p107, E2f1, E2f4 Proliferation, Differentiation PPARγ Fajas et al. (2002b)
Osteoblasts pRb, E2f1 Differentiation Alpl, Bglap Flowers et al. (2013)
Liver oval SC pRb, E2f1 Quiescence, Expansion Notch pathway Viatour et al. (2011)
Pancreatic/endocrine SCs E2f1 Proliferation, Differentiation Ngn3 Kim and Rane (2011)
Trophoblast SC pRb, E2f3, E2f7, E2f8 Proliferation, Differentiation,
Survival
Spermatogonial SC pRb Self-renewal
Also indicated are the specific E2F and PP factors that have been implicated functionally, as well as the cell fate regulatory process known to be controlled by E2F/PPs,
in each stem/progenitor cell type. Where examples are known and have been functionally validated, we give key examples of direct cell fate regulatory genes that
are transcriptional targets of E2Fs/PPs. The references listed are specific to the target genes given. ∗∗ Indicates that genome-wide analyses (represented among the
references) have uncovered additional putative target genes in that cell type. The cell fate process ‘expansion’ encompasses the potential for both proliferation and/or
self-renewal.
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et al., 2007), another core regulator of neural stem cell mainte-
nance. Additionally, p107 and E2f3 control NPC proliferation in
the developing brain through regulation of the ﬁbroblast growth
factor Fgf2 (McClellan et al., 2009).
These studies reveal a highly dynamic role for PPs and E2F
factors in CNS development and homeostasis. Furthermore, they
heavily implicate transcriptional regulation of non-canonical, cell
fate-associated genes as a driving mechanism behind E2F/PP-
dependent function in stem and progenitor populations. In line
with the situation in the CNS, E2F/PP activity has also recently
been implicated in controlling the self-renewal potential of
pluripotent ESCs in mammals. Transcriptomic and transcription
factor motif analyses in human ESCs suggested a fundamen-
tal role for E2F factors in the self-renewal of pluripotent stem
cells (Yeo et al., 2011), which has been conﬁrmed functionally
(Conklin et al., 2012; Suzuki et al., 2014). This study suggested
that E2Fs were highly integrated in the self-renewal network, and
our recent bioinformatics analysis of E2f3 and E2f4 direct bind-
ing sites in murine NPCs conﬁrmed that E2fs do indeed bind to
an extensive network of genes fundamental for self-renewal and
stem cell function (Julian et al., 2015).
This identiﬁcation of E2Fs as important regulators of stem
cell self-renewal and associated core regulatory genes has impor-
tant implications not only for tissue homeostasis and devel-
opment, but also the tumorigenic or tumor suppressive role
of E2F and PP factors. An interesting possibility is that can-
cer may arise due to a loss of the ability to control expres-
sion of stem cell self-renewal genes, in addition to bona ﬁde
cell cycle genes. Supporting this assertion, two recent studies
demonstrated a pivotal role for E2F/PP complexes in inhibit-
ing cellular reprogramming to pluripotency. Speciﬁcally, two
forms of transcriptional repressive complexes, pRb/E2f as well
as p130/E2f4 in complex with the Cyclin-dependent kinase
inhibitor p27, were shown to function as inhibitory blocks to
reprogramming (Li et al., 2012; Kareta et al., 2015). Intriguingly,
the underlying mechanisms were independent of cell cycle con-
trol, but due to transcriptional repression of Sox2 expression
during the reprogramming process. Furthermore, the ability of
pRb/E2f to repress Sox2 expression appeared to be a critical
tumor-suppressive mechanism (Kareta et al., 2015). These stud-
ies, together with the ﬁndings of E2f-dependent Sox2 regulation
in NPCs (Julian et al., 2013), establish the E2F/PP regulatory
node as an essential regulator of one of the most fundamental
stem cell identity genes, importantly in two primary cell types
that rely heavily on Sox2 for maintenance of their stem cell
pool.
Regulation of Genes that Control Cell Death
and Survival
A role for E2Fs and PPs in mediating cell death and/or survival
has been functionally described in many lineages. Although this
biological role has been known for some time, the mechanisms
aﬀecting cell death in stem and progenitor cells due to dereg-
ulation of E2Fs or PPs is not fully clariﬁed. Nevertheless, p53-
dependent mechanisms have been highly implicated, and while
recent evidence suggested a non-transcriptional role for pRb in
apoptotic induction (Hilgendorf et al., 2013), a number of genes
that are involved in both the mitochondrial apoptotic signaling
cascade as well as autophagy regulation have been demonstrated
as downstream or direct targets of E2Fs and/or PPs (Hiebert
et al., 1995; Sherr, 1998; Irwin et al., 2000; Moroni et al., 2001;
Nahle et al., 2002; Vorburger et al., 2002; Hershko and Ginsberg,
2004; Hershko et al., 2005; Tracy et al., 2007; Ianari et al., 2009;
Conklin et al., 2012; Bertin-Ciftci et al., 2013; Sung et al., 2013;
Benson et al., 2014). Furthermore, a speciﬁc biochemical inter-
action between pRB and E2F1 is required for regulation of both
E2F1-induced apoptosis and expression of E2F-dependent apop-
totic genes (Dick and Dyson, 2003; Julian et al., 2008; Carnevale
et al., 2012), strongly suggesting that transcriptional regulation by
E2F/PP is a primary mechanism by which this pathway controls
cell death.
Transcriptional Regulation of Metabolism by
E2Fs/PPs
In addition to cell cycle dynamics and execution of stem cell-
speciﬁc gene regulatory networks, a plethora of recent work has
revealed an essential role for metabolic adaptations in driving
the stem cell state. Speciﬁcally, it has become clear that stem
cells inhibit oxidative metabolism and depend onmetabolic path-
ways that rely heavily on glycolysis for energy production (Folmes
et al., 2013; Ochocki and Simon, 2013). Given this knowledge,
recent ﬁndings demonstrating a requirement for E2F and PP fac-
tors to both inhibit oxidative phosphorylation/promote glycolytic
pathways in muscle and adipose tissue and to repress expression
of genes associated with oxidative metabolism, such as PGC1α,
are particularly intriguing (Scimè et al., 2010; Blanchet et al.,
2011).While the functional relevance of E2F/PP-dependent regu-
lation of core metabolism genes has not been investigated in stem
cell populations, genome-wide studies have identiﬁed numerous
metabolism-related genes as putative E2F targets (Asp et al., 2009;
Yeo et al., 2011; Julian et al., 2015). Importantly, these discov-
eries in addition to others discussed here, place E2Fs and PPs
as pivotal transcriptional regulators of multiple essential biologi-
cal processes and regulatory programs that control stem cell fate
decisions (Figure 1).
Mechanisms of Cell Fate Gene
Regulation by E2F/PPs
As discussed above, the cell fate-associated processes with which
E2Fs and PPs have been functionally implicated are diverse. In
mammals, the PP and E2F families are now known to impact
cell fate determination in many lineages. This includes neu-
ronal, mesenchymal, hematopoietic, muscle, intestinal, mam-
mary gland, liver, trophoblast, spermatogonial, and pluripotent
stem and progenitor cells [for a thorough review on many of
these lineages, see (Daria et al., 2008; Viatour et al., 2008; Ouseph
et al., 2012; Sage, 2012; Hu et al., 2013; Yang et al., 2013; Suzuki
et al., 2014; Rotgers et al., 2014; Kareta et al., 2015]. Thus the cur-
rent evidence suggests that these proteins play instructive roles
in stem and progenitor cell types that encompass all embryonic
germ layers, as well as extra-embryonic, germ cell, and pluripo-
tent lineages (Figure 2 and Table 1). While our understanding of
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FIGURE 2 | E2Fs and PPs regulate cell fate in diverse stem cell
populations. Here, we highlight examples of mammalian stem cell (SC)
populations in which biological roles for E2Fs and/or PPs in cell fate regulation,
outside of classical cell cycle control, have been documented. These cell types
include SC populations representing all three embryonic germ layers (ectoderm,
mesoderm, endoderm), as well as pluripotent SCs (in ESCs as well as during
cellular reprogramming to iPSCs), germ (spermatogonial) SCs, and
extra-embryonic trophoblasts. We indicate the E2F and PP factors that have
been implicated in cell fate regulation in each SC type. See the main text or
Table 1 for references.
the full extent of stem and progenitor lineages that are aﬀected
by E2F/PP fate control is incomplete, these ﬁndings suggest that
E2F/PP-dependent mechanisms are pervasive and perhaps fun-
damental for stem cell fate control. Additionally, they suggest
that E2F and PP factors may have the capacity to regulate unique
classes of cell fate regulatory genes in diﬀerent tissue types.
While the extent of tissue-speciﬁc gene regulation by E2F/PPs is
poorly understood, emerging data suggests that it is extensive and
likely to involve multiple mechanisms to inﬂuence target gene
selection.
Regulation of Tissue-Specific Genetic
Networks
A long-standing theory proposed to explain the ability of cell
cycle regulators to potentiate tissue-speciﬁc diﬀerentiation pro-
grams, on a biological level, is that PPs interact with transcrip-
tional co-factors other than E2Fs that are unique to speciﬁc
tissues and that regulate tissue-speciﬁc target genes. Indeed, pRb
has been shown to complex with transcription factors other
than E2Fs in a manner that aﬀects progenitor cell diﬀerentia-
tion, one prominent example being its interaction with Runx2
in the osteoblast lineage to regulate the expression of osteoblast-
speciﬁc genes (Thomas et al., 2001). An interaction between pRb
and MyoD in muscle cells has also been reported (Gu et al.,
1993), but it is likely that the interplay between the PP and the
master regulator of myogenesis occurs indirectly, through com-
petition for binding to the transcriptional co-repressor HDAC1
(Mal et al., 2001; Puri et al., 2001). pRb has also been shown to
repress adipocyte diﬀerentiation by interacting with PPARγ and
recruiting HDAC1 to its target promoters (Fajas et al., 2002a),
and to stimulate adipogenesis by interacting with CEBP tran-
scription factors (Chen et al., 1996). Additionally, stabilization
of the homeobox protein Pdx1 through a direct interaction with
pRb is necessary for embryonic pancreas development and adult
β-cell function (Kim et al., 2011). It is likely that more tissue-
speciﬁc interactions of this kind will be discovered as this line of
investigation progresses.
Independently from these possibilities, however, the evidence
that is now emerging from a deeper analysis of E2F target genes
in individual cell types suggests that a prominent mechanism by
which cell cycle regulators control tissue-speciﬁc cell fate deci-
sions is through E2F-dependent regulation of networks of cell
fate regulatory genes that are speciﬁc to that lineage. Due to the
accumulating evidence that E2Fs and PPs can control cell fate
processes without aﬀecting cell cycle dynamics, and the expand-
ing number of direct E2F target genes that control tissue-speciﬁc
stem cell fate decisions (Fajas et al., 2002b; Ruzhynsky et al., 2007;
Asp et al., 2009; McClellan et al., 2009; Andrusiak et al., 2011;
Ghanem et al., 2012; Li et al., 2012; Julian et al., 2013; Kareta et al.,
2015), we anticipate that further investigations into the genome-
wide binding sites of E2Fs in diﬀerent cell types will solidify the
hypothesis that E2Fs target large networks of tissue-speciﬁc tar-
get genes. Speaking to this, a recent study identiﬁed extensive
tissue-speciﬁcity in the binding sites of E2F and PP orthologs in
germline and somatic cell populations inC. elegans (Kudron et al.,
2013). In mammalian cells, comparative analysis of E2f3-bound
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gene promoters in murine NPCs and myoblasts showed that
while cell cycle-related target genes are common to both cell
types, there is a large degree of tissue-speciﬁcity among E2f3 tar-
get sites, speciﬁcally at those genes involved in diﬀerentiation and
development-related processes (Julian et al., 2015; Figure 3). To
understand how widespread this phenomenon is, it is impera-
tive that systematic analysis of genome-wide E2F binding sites,
and corresponding gene expression analyses, be performed in a
much more expansive group of mammalian tissues and primary
cell types.
Diverse Transcriptional Roles of E2Fs and
E2F/PP Complexes
Multiple lines of evidence suggest that E2F/PP-mediated regu-
lation of cell fate-associated genes does not closely follow the
canonical view that E2Fs1-3a are predominantly transcriptional
activators, and the remaining E2Fs are predominantly repres-
sors that function in cooperation with a PP. First, the fact that
genomic binding studies have identiﬁed both ‘activator’ and
‘repressor’ E2Fs at seemingly active promoters, in multiple stem
and progenitor cell types, does not support this canonical view
(Asp et al., 2009; Yeo et al., 2011). A number of observations from
single gene-focused analyses have further revealed that E2F tran-
scriptional function is more complex than the canonical model
suggests. Unexpectedly, the E2f3-mediated regulation of Sox2
in NPCs was paradoxically found to be dependent on a tran-
scriptional activation role for E2f3b and a repressive role for the
classical ‘activator’ E2f3a (Julian et al., 2013). Additionally, this
repressive role for E2f3a appears to function in concert with p107,
an atypical binding partner for E2f3a as it is was thought to only
form PP-containing complexes with pRb. Interestingly, E2f3a has
also been shown to mediate repression in starburst amacrine cells
in the retina, this time through collaboration with pRb (Chen
et al., 2007). Additionally, a role for pRb/E2f1 complexes in
gene activation has been demonstrated at select genes involved
in osteogenic, adipogenic, and myogenic diﬀerentiation (Flowers
et al., 2013), while alternatively, pRb-independent gene repres-
sion by E2f3b, across a large panel of genes, has also been
observed (Asp et al., 2009).
Intriguingly, the simultaneous identiﬁcation of biologically
functional E2f3b activator and E2f3a/p107 repressor complexes
at the same target gene, Sox2, in proliferating NPCs, suggests that
a homeostatic level of E2F and PP family members is required
to ensure proper regulation of at least some target genes. By
this mechanism, proper biological function would be dependent
on ﬁnely tuned transcriptional regulation by E2F and PPs, as
opposed to strict ‘on/ oﬀ’ activation or repression by speciﬁc
transcriptional complexes. The requirement for opposing regu-
lation of Sox2 by E2fs/PPs to regulate the balance between NPC
maintenance and diﬀerentiation (Julian et al., 2013), as well as
ﬁndings that both pRB over-expression and deﬁciency in human
ESCs induces cell cycle arrest and death (Conklin et al., 2012), and
that both loss or gain of E2f expression drives survival defects in
retinal progenitors (Chen et al., 2009a; Chong et al., 2009b), are
testaments to this possibility.
Together, these ﬁndings paint a more malleable picture of
transcriptional regulation by E2Fs and PPs than what the canon-
ical model suggests, where the potential combinations of E2F
and PP factors at DNA sites and their resulting transcriptional
eﬀects are in fact diverse and not clearly predictable. The com-
plexes that are formed and their transcriptional eﬀects at cell fate
regulatory target genes are likely to be inﬂuenced by a number
of factors, including cell type- and state-speciﬁc expression pro-
ﬁles of E2F and PP family members and additional co-factors,
as well as the chromatin environment that surrounds particular
E2F-bound sites. Thus, it is likely that transcriptional regulation
by E2Fs and E2F/PP complexes can vary signiﬁcantly at diﬀerent
genomic sites and in diﬀerent cellular states.
FIGURE 3 | Tissue-specific gene regulation by E2F3. Genome-wide
analyses in precursors of skeletal muscle and neurons have revealed the
existence of tissue-specific target genes, as well as genes that are likely
to be constitutively regulated in most tissues. Constitutive and
tissue-specific E2f3 targets are enriched in different functional categories
(gene ontologies), with cell cycle-related functions being most represented
by constitutive targets of E2f3. Additionally, gene promoter sequence
analyses suggest that E2f3 may cooperate with different transcriptional
regulators, depending on the cell type: with Nrf1 (Cam et al., 2004), Sp1
(Blais et al., 2002), and NF-y (Caretti et al., 2003; Elkon et al., 2003;
Zhu et al., 2004) for constitutive cell cycle target genes, with Ctcf in
neural precursors (Julian et al., 2015) and with MyoD and Runx in
myoblasts [unpublished analyses performed using Whole Genome rVista
(Dubchak et al., 2013)].
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Transcriptional Co-Factors and E2F Target
Gene Selection
Given the association of E2F and PP factors with cell fate regu-
lation in what is now known to be a considerably broad range
of cell types, especially with the potential tissue-speciﬁcity of
this phenomenon, understanding how these proteins are able
to physically discern between their canonical cell cycle regula-
tory genes and their non-canonical targets becomes an important
question. The fact that many E2F/PP-dependent cell fate reg-
ulatory functions can be functionally separated from cell cycle
control suggests that these proteins are recruited to ‘cell cycle’
and ‘cell fate’ genes with the help of diﬀerent transcriptional
partners.
While a prospective analysis of potential E2F co-factors that
may speciﬁcally regulate cell fate genes has not been reported, two
co-factors for E2F3, to date the most highly implicated E2F fam-
ily member in cell fate control, have been identiﬁed. Speciﬁcally,
the E-box transcription factor TFE3 has been shown to inter-
act uniquely with E2F3 through its marked box domain and
to regulate proliferation and the expression of select genes in
cooperation with E2F3 (Giangrande et al., 2003; Nijman et al.,
2006). Additionally, a recent study demonstrated that the SNF2-
like helicase protein HELLS interacts with E2F3 in the context
of tumorigenesis to induce cell cycle entry and proliferation,
and that the two appear to synergistically activate select target
genes (von Eyss et al., 2012). These studies implicated TFE3
and HELLS as E2F3 co-factors largely in the context of pro-
liferative control. It is possible that these interactions have the
same functional consequence in all cell types; however, it may
also be the case that TFE3 and HELLS are important factors
in the recruitment and/or activity of E2F3 to cell fate regula-
tory genes in stem cell populations. As the functional impli-
cations and conservation of these interactions have not been
extensively characterized, this possibility warrants further inves-
tigation.
In addition to potential co-factors that may recruit E2Fs to
target sites, recruitment of E2Fs to target genes can also be regu-
lated by mechanisms that compete for their ability to bind DNA.
For instance, the Cyclin-dependent kinase CDK5 is a potent cell
cycle suppressor in post-mitotic neurons (Zhang et al., 2008),
and the underlying mechanism is due to the ability of a CDK5-
p35 complex to directly bind E2F1, consequently disrupting the
ability of E2F1 to interact with DP1 on DNA at various cell cycle-
related genes (Zhang et al., 2010). As enzymatically active CDK5
is restricted to post-mitotic neurons, studies have largely focused
on determining its function in this cell type. However, the mech-
anism described here is not dependent on enzymatic activity, and
since CDK5 is broadly expressed (Tsai et al., 1993) this unique
E2F regulatory mechanism may be important in other cell types.
It is unclear at the moment if such a mechanism may similarly
contribute to the regulation of cell fate regulatory genes by E2Fs
in neural cells or other lineages, but it is a promising possibility
that this or a similar mechanism contributes to E2F target gene
speciﬁcity.
Another intriguing possibility is that interaction between
E2Fs and PPs with enhancer regions may underlie the abil-
ity of these proteins to bind to potentially unique sets of cell
fate associated genes in diﬀerent cell types, as enhancers are
key mediators of cell type-speciﬁc gene regulation. The recent
ﬁnding that a signiﬁcant proportion of E2F4 binding sites are
directly associated with enhancers lends credence to this idea
(Lee et al., 2011). Furthermore, gene promoter sequence anal-
ysis of E2f3-bound promoter sites has identiﬁed a few select
factors that may discern common and tissue-speciﬁc E2f tar-
get sites in NPCs and myoblasts (Julian et al., 2015; unpub-
lished data; Figure 2). Intriguingly, further bioinformatic anal-
yses revealed CTCF as a potential novel co-factor for E2f3 at
cell fate genes speciﬁcally in NPCs. CTCF is a well-known
insulator protein associated with enhancer regions and, as
recently demonstrated, with a sub-population of promoter sites
(Shen et al., 2012; Phillips-Cremins and Corces, 2013). Given
the particular importance of CTCF in neuronal development
(Hirayama et al., 2012), enhancer–promoter connections medi-
ated between CTCF and E2F represents a particularly promis-
ing mechanism for NPC-speciﬁc cell fate gene regulation by
E2F/PPs.
As the identity of protein complexes found at enhancer regions
and their interactions with promoters is a major mechanism
dictating cell type-speciﬁc gene expression, this is an excit-
ing ﬁnding that suggests E2Fs may inﬂuence tissue-speciﬁc cell
fate control by coordinating enhancer–promoter interactions
at key cell fate associated genes. Application of ChIP-Seq to
identify truly unbiased genome-wide binding sites of additional
E2F factors in a greater diversity of cell types will importantly
reveal how widespread this phenomenon is among the E2F
family. Coupling this approach with genomic structural anal-
yses, such as Hi-C technology, which allows for identiﬁcation
of chromatin loop domains and associated chromatin marks
and binding proteins (Rao et al., 2014), will provide an impor-
tant perspective on the potential functional implications of these
interactions.
Conclusion and Perspectives
The relatively recent technical progress in systems biology
approaches to understanding gene regulation on a genome-wide
level has revealed an extensive diversity of function for the clas-
sical cell cycle regulatory E2F/PP pathway. We now know that
transcriptional regulation of extensive sets of cell fate regulatory
genes by E2Fs and PPs is an important regulatory mechanism
underlying key cell fate decisions in a number of cell types.
Emerging evidence also suggests that the E2F/PP signaling node
is able to mediate cell type-speciﬁc gene expression programs.
While advances over the past few years have greatly expanded
our view of the functional importance of transcriptional regu-
lation by E2Fs and PPs, the mechanistic understanding of their
role in stem cell fate regulation is in its infancy. We need a bet-
ter understanding of which stem cell populations rely on E2F/PP
activity when making key cell fate decisions, as well as which epi-
genetic co-factors contribute to gene class and cell type-speciﬁc
gene expression.
Moving forward it will be important to continue to exploit
advances in systems biology approaches that allow for truly
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genome-wide analyses of transcription factor binding sites in
order to understand the full extent of E2F/PP function in stem
cell fate control. Correlation of putatively identiﬁed target genes
with gene expression signatures, co-factor binding, and both two-
and three-dimensional chromatin structure will shed important
mechanistic insight on the epigenetic role of E2Fs/PPs in cell fate
decision making.
An important question for future investigations, which is cur-
rently largely unaddressed, is how E2Fs and PPsmay regulate cell
fate genes in post-mitotic cells. There is extensive evidence that
PPs and E2Fs can repress cell cycle entry in post-mitotic cells and
that they can participate in the formation of multi-protein repres-
sive complexes in these cell types to repress classical E2F cell
cycle target genes [reviewed in Blais and Dynlacht (2007), Dick
and Rubin (2013), Herrup (2013)]. It is therefore likely that E2Fs
and PPs are important regulators of cell fate-associated genes
in post-mitotic cells, in both normal and disease settings, per-
haps to repress the stem cell state, or to maintain diﬀerentiation
and survival. Gaining a clearer understanding of the mecha-
nisms underlying epigenetic cell fate regulation by E2Fs/PPs by
addressing these key questions will have important implications
in the contexts of tumorigenesis and disease, development, tissue
homeostasis, and regeneration.
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